TLR4-Dependent Claudin-1 Internalization and Secretagogue-Mediated Chloride Secretion Regulate Irinotecan-Induced

Hannah R Wardill1,2, Joanne M Bowen3, Ysabella Z A Van Sebille3

  • 1Discipline of Anatomy and Pathology, School of Medicine, University of Adelaide, Adelaide, South Australia, Australia. hannah.wardill@adelaide.edu.au.

Insights

Toll-like receptor 4 (TLR4) plays a key role in irinotecan-induced intestinal damage. Genetic deletion of TLR4 protects mice from irinotecan

Area of Science:

  • Gastroenterology
  • Immunology
  • Pharmacology

Background:

  • Irinotecan chemotherapy can cause intestinal injury and diarrhea.
  • Toll-like receptor 4 (TLR4) has been implicated in irinotecan-induced intestinal permeability.
  • The precise role of TLR4 in regulating intestinal tight junctions and secretion during irinotecan treatment requires further elucidation.

Purpose of the Study:

  • To investigate the molecular characteristics of intestinal tight junctions in wild-type and Tlr4-deficient (Tlr4-/-) mice treated with irinotecan.
  • To characterize the secretory profile of the distal colon in response to irinotecan in a Tlr4-dependent manner.
  • To elucidate the contribution of TLR4 to irinotecan-induced diarrhea.

Main Methods:

  • BALB/c mice (wild-type and Tlr4-/-) were administered irinotecan or vehicle.
  • Intestinal permeability was assessed using FITC-dextran.
  • Tight junction integrity was evaluated via immunofluorescence, Western blotting, and RT-PCR.
  • Distal colon secretion was measured using Ussing chambers with carbachol and forskolin stimulation.

Main Results:

  • Irinotecan induced claudin-1 internalization and ZO-1/occludin proteolysis in wild-type mice, leading to increased intestinal permeability.
  • Tlr4-/- mice exhibited preserved tight junction integrity and normal barrier function.
  • Baseline conductance and carbachol-induced chloride secretion were elevated in irinotecan-treated wild-type mice, but not in Tlr4-/- mice.

Conclusions:

  • TLR4 signaling is critical for irinotecan-induced disruption of intestinal tight junctions, specifically claudin-1 internalization.
  • TLR4-dependent mechanisms contribute to increased intestinal permeability and altered colonic secretion, leading to diarrhea.
  • Targeting TLR4 may offer a therapeutic strategy to mitigate irinotecan-induced gastrointestinal toxicity.

Related Concept Videos

Drugs for Treatment of Constipation-Predominant IBS01:21

Drugs for Treatment of Constipation-Predominant IBS

Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
1.1K
Drugs for Treatment of Diarrhea-Predominant IBS01:17

Drugs for Treatment of Diarrhea-Predominant IBS

Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
836
Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents01:17

Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents

Diarrhea, a condition marked by frequent loose or watery bowel movements, can be triggered by multiple factors such as viral or bacterial infections, food intolerances, anxiety, medications, and digestive disorders. Symptoms may include abdominal pain, bloating, nausea, and cramping. Severe or prolonged diarrhea can lead to complications like electrolyte imbalances, malnutrition, and dehydration if left untreated.
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
811
Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents01:20

Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents

Diarrhea is characterized by the occurrence of frequent, watery bowel movements. Various factors can trigger diarrhea, including viral or bacterial infections, foodborne illnesses, side effects from certain medications, and underlying digestive disorders. If not adequately managed, diarrhea can lead to complications such as dehydration, electrolyte imbalances, and nutrient deficiencies. Severe diarrhea can lead to significant weight loss, malnutrition, and weakened immune function.
Adsorbents...
719
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents01:18

Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents

Acute diarrhea, a common gastrointestinal disturbance, is characterized by the rapid evacuation of fluid stools, leading to an excessive weight in fluid. This condition typically arises from disorders affecting intestinal water and electrolyte transport. It can be triggered by an increased osmotic load within the intestine, excessive secretion of electrolytes and water, mucosal exudation of protein and fluid, or altered intestinal motility. The primary risks of acute diarrhea are dehydration...
522
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
639